Terms: = Liver cancer AND LRP1B, ENSG00000168702, 53353, Q9NZR2, LRPDIT, LRP-DIT
18 results:
1. Comprehensive Mutation Profiling of Colorectal cancer Patients With Lung or liver Metastasis by Targeted Next-Generation Sequencing.
Hu CT; Wang JL; Hou T; Yan ZW; Zu LD; Fu GH; Shen WW
Technol Cancer Res Treat; 2023; 22():15330338231185285. PubMed ID: 37394872
[TBL] [Abstract] [Full Text] [Related]
2. Preliminary radiogenomic study of hepatitis B virus-related hepatocellular carcinoma: associations between MRI features and mutations.
Gao S; Wang F; Sun W; Qian X; Ji Y; Cheng Y; Wang X; Liu L; Sheng R; Zeng M
Per Med; 2023 May; 20(3):215-225. PubMed ID: 37199498
[TBL] [Abstract] [Full Text] [Related]
3. A lipid metabolism-based prognostic risk model for HBV-related hepatocellular carcinoma.
Zhou L; Xia S; Liu Y; Ji Q; Li L; Gao X; Guo X; Yi X; Chen F
Lipids Health Dis; 2023 Apr; 22(1):46. PubMed ID: 37004044
[TBL] [Abstract] [Full Text] [Related]
4. Profound tumor response to combined CTLA-4 and PD-1 inhibition in systemic fourth line therapy observed in a patient with hepatocellular carcinoma harboring SETD2 and lrp1b mutations.
Reiter FP; Rau M; Kunzmann V; Kickuth R; Klein I; Neumann O; Stenzinger A; Schirmacher P; Geier A
Z Gastroenterol; 2023 Jan; 61(1):71-75. PubMed ID: 36379463
[TBL] [Abstract] [Full Text] [Related]
5. Mutational and transcriptional alterations and clinicopathological factors predict the prognosis of stage I hepatocellular carcinoma : Prediction of stage I HCC prognosis.
Li Z; Gao H; Zhang X; Liu Q; Chen G
BMC Gastroenterol; 2022 Sep; 22(1):427. PubMed ID: 36153509
[TBL] [Abstract] [Full Text] [Related]
6. lrp1b mutation associates with increased tumor mutation burden and inferior prognosis in liver hepatocellular carcinoma.
Yu G; Mu H; Fang F; Zhou H; Li H; Wu Q; Xiong Q; Cui Y
Medicine (Baltimore); 2022 Jul; 101(26):e29763. PubMed ID: 35777027
[TBL] [Abstract] [Full Text] [Related]
7. Preoperative serum ctDNA predicts early hepatocellular carcinoma recurrence and response to systemic therapies.
Fu Y; Yang Z; Hu Z; Yang Z; Pan Y; Chen J; Wang J; Hu D; Zhou Z; Xu L; Chen M; Zhang Y
Hepatol Int; 2022 Aug; 16(4):868-878. PubMed ID: 35674872
[TBL] [Abstract] [Full Text] [Related]
8. Comprehensive analysis of metabolic pathway activity subtypes derived prognostic signature in hepatocellular carcinoma.
Huo J; Cai J; Wu L
Cancer Med; 2023 Jan; 12(1):898-912. PubMed ID: 35651292
[TBL] [Abstract] [Full Text] [Related]
9. Downregulation of Low-density lipoprotein receptor-related protein 1B (lrp1b) inhibits the progression of hepatocellular carcinoma cells by activating the endoplasmic reticulum stress signaling pathway.
Zhen Z; Shen Z; Sun P
Bioengineered; 2022 Apr; 13(4):9467-9481. PubMed ID: 35389768
[TBL] [Abstract] [Full Text] [Related]
10. Multi-omics data identified TP53 and lrp1b as key regulatory gene related to immune phenotypes via EPCAM in HCC.
Shi L; Cao J; Lei X; Shi Y; Wu L
Cancer Med; 2022 May; 11(10):2145-2158. PubMed ID: 35150083
[TBL] [Abstract] [Full Text] [Related]
11. Identification of driver genes and target drugs-related genes in liver cancer based on targeted next generation sequencing.
Cui Y; Sun L; Wang H; Zhang Z; Dai H; Liu P
Neoplasma; 2022 Jan; 69(1):95-102. PubMed ID: 34704453
[TBL] [Abstract] [Full Text] [Related]
12. Paired comparisons of mutational profiles before and after brachytherapy in asian uveal melanoma patients.
Lee WS; Lee J; Choi JJ; Kang HG; Lee SC; Kim JH
Sci Rep; 2021 Sep; 11(1):18594. PubMed ID: 34545149
[TBL] [Abstract] [Full Text] [Related]
13. Development and validation of lrp1b mutation-associated prognostic model for hepatocellular carcinoma.
Xu J; Shen X; Zhang B; Su R; Cui M; Yan L; Cao Y
Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34386813
[TBL] [Abstract] [Full Text] [Related]
14. Mutational spectrum and precision oncology for biliary tract carcinoma.
Lin J; Cao Y; Yang X; Li G; Shi Y; Wang D; Long J; Song Y; Mao J; Xie F; Bai Y; Zhang L; Yang X; Wan X; Wang A; Guan M; Zhao L; Hu K; Pan J; Huo L; Lu X; Mao Y; Sang X; Zhang H; Wang K; Wang X; Zhao H
Theranostics; 2021; 11(10):4585-4598. PubMed ID: 33754015
[No Abstract] [Full Text] [Related]
15. The combination of camrelizumab and apatinib obtained ongoing partial remission for a patient with osimertinib-resistant non-small cell lung cancer: case report.
Cong X; Chen J; Zheng W
Ann Palliat Med; 2021 Mar; 10(3):3469-3474. PubMed ID: 33040541
[TBL] [Abstract] [Full Text] [Related]
16. Near-Comprehensive Resequencing of cancer-Associated Genes in Surgically Resected Metastatic liver Tumors of Gastric cancer.
Ikari N; Serizawa A; Mitani S; Yamamoto M; Furukawa T
Am J Pathol; 2019 Apr; 189(4):784-796. PubMed ID: 30703342
[TBL] [Abstract] [Full Text] [Related]
17. Recurrent targeted genes of hepatitis B virus in the liver cancer genomes identified by a next-generation sequencing-based approach.
Ding D; Lou X; Hua D; Yu W; Li L; Wang J; Gao F; Zhao N; Ren G; Li L; Lin B
PLoS Genet; 2012; 8(12):e1003065. PubMed ID: 23236287
[TBL] [Abstract] [Full Text] [Related]
18. Homozygous deletion scanning in hepatobiliary tumor cell lines reveals alternative pathways for liver carcinogenesis.
Pineau P; Marchio A; Nagamori S; Seki S; Tiollais P; Dejean A
Hepatology; 2003 Apr; 37(4):852-61. PubMed ID: 12668978
[TBL] [Abstract] [Full Text] [Related]
